Robert Bradley Paull

Insider Reports History

Location
100 Beaver Street, Suite 201, Waltham, MA
Signature
/s/ Mary Reumuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Bradley Paull:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kala Pharmaceuticals, Inc. Director Common Stock 40K $270K $6.74 Jun 17, 2021 Direct
Kala Pharmaceuticals, Inc. Director Common Stock 2.36K $15.9K $6.74 Jun 17, 2021 Indirect
Kala Pharmaceuticals, Inc. Director Stock Option (right to buy) 40K Jun 16, 2022 Direct

Insider Reports Filed by Robert Bradley Paull

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALA Kala Pharmaceuticals, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
KALA Kala Pharmaceuticals, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director